Chemistry involves the study of all things, chemical manipulation – in order to better understand the way in which materials are structured, how they change and how they react in certain situations. In a patent, 26364-65-8, name is 2-Cyanoimino-1,3-thiazolidine, introducing its new discovery. Electric Literature of 26364-65-8
Purine derivatives that inhibit cellular necroptosis and/or human MLKL, pharmaceutical compositions thereof, and methods of treating an MLKL-mediated disorder with an effective amount of the compound or composition. Said MLKL-mediated disorder is pathology associated necroptosis, including ischemia-reperfusion damage, neurodegeneration, and inflammatory diseases such as acute pancreatitis, multiple sclerosis, inflammatory bowel disease, and allergic colitis.
This is the end of this tutorial post, and I hope it has helped your research about 26364-65-8. Electric Literature of 26364-65-8
Reference：
Quinuclidine – Wikipedia,
Quinuclidine | C7H623N | ChemSpider